U.S. Markets open in 24 mins

CVS Caremark Corp Quarterly Earnings on Deck

S&P 500 component CVS Caremark Corp will unveil its latest earnings on Thursday, August 4, 2011. CVS Caremark Corporation provides prescriptions and related health care services and products.

Investing Insights:   Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

CVS Caremark Corp Earnings Preview Cheat Sheet

Wall St. Earnings Expectations: The average estimate of analysts is for profit of 64 cents per share, a decline of 1.5% from the company’s actual earnings for the same quarter a year ago. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged and it has not changed during the last month. For the year, analysts are projecting net income of $2.78 per share, a rise of 3.3% from last year.

Past Earnings Performance: The company’s quarterly results have come in above estimates for the last three quarters. Last quarter, the company booked profit of 57 cents per share versus a mean estimate of net income of 55 cents per share.

Get more Earnings Cheat Sheets with our in depth coverage of earnings season >>

Wall St. Revenue Expectations: On average, analysts predict $26.76 billion in revenue this quarter, a rise of 11.5% from the year ago quarter. Analysts are forecasting total revenue of $108.18 billion for the year, a rise of 12.2% from last year’s revenue of $96.41 billion.

Analyst Ratings: Analysts are bullish on this stock with 18 analysts rating it as a buy, none rating it as a sell and six rating it as a hold.

Key Stats:

A year-over-year revenue increase in the first quarter snaps a streak of three consecutive quarters of revenue declines. Revenue rose 8.9% in the first quarter and fell 4.1% in the fourth quarter of the last fiscal year, 3.1% in the third quarter of the last fiscal year and 3.5% in the second quarter of the last fiscal year.

While the company has been profitable for the last eight quarters, income has fallen year over year by an average of 9.5% over the past four quarters. The quarter hit the hardest was the third quarter of the last fiscal year, that saw a 20.8% drop.

Competitors to Watch: Walgreen Company , Rite Aid Corporation , PharMerica Corporation , Medco Health Solutions Inc. , drugstore.com, inc. , PetMed Express, Inc. , Graymark Healthcare Inc , BioScrip Inc. .

Stock Price Performance: During June 2, 2011 to August 3, 2011, the stock price had fallen $2.63 (-7%) from $38.40 to $35.77. The stock price saw one of its best stretches over the last year between November 30, 2010 and December 14, 2010 when shares rose for 11-straight days, rising 9.9% (+$3.05) over that span. It saw one of its worst periods between July 7, 2011 and July 18, 2011 when shares fell for eight-straight days, falling 4.7% (-$1.79) over that span. Shares are up $1 (+2.88%) year to date.

(Source: Xignite Financials)

Investing Insights:   Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>